In women, APOE4 genotype is a stronger risk factor for developing AD from ages 65 to 75 years compared to men and confers disproportionate adverse effects on AD biomarkers at each disease stage (Neu et al., 2017; Sundermann et al., 2018). Here, APOE is linked to Alzheimer disease.